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Abstract
Background: Ataxia with vitamin E deficiency (AVED) is an autosomal recessive disorder that usually presents with ataxia, areflexia, and proprioceptive and
vibratory sensory loss. Dystonia has been reported rarely.
Case Report: An 11-year-old female presented with dystonic head tremor and cervical and bilateral arm dystonia. Her 14-year-old older brother had dystonic
head tremor and generalized dystonia. One year later, the brother developed dysarthria, limb dysmetria, and gait ataxia. Compound heterozygous mutations in
TTPA were detected, confirming the diagnosis of AVED.
Discussion: AVED may present with dystonia rather than ataxia, and should be considered in the differential diagnosis of progressive dystonia.
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Introduction
Ataxia with vitamin E deficiency (AVED) is a rare, autosomal
recessive neurodegenerative disorder, with approximately 225
reported cases in over 100 families. Mutations in the gene encoding
the a-tocopherol transfer protein (TTPA/aTTP) result in normal
intestinal absorption of vitamin E but defective transportation out of
the liver, resulting in systemic vitamin E deficiency.1 The disease
typically presents in childhood with progressive ataxia, areflexia, and
loss of proprioceptive and vibratory sense, resembling Friedreich’s
ataxia.2,3 Early diagnosis is imperative, as treatment can halt or even
reverse disease progression.3,4
Dystonia occurs rarely in AVED and has been described as a
presenting feature only once previously, in a child who presented with
a syndrome that resembled myoclonic dystonia.5 We present the
clinical and genetic features and initial treatment response of two
siblings with AVED who presented atypically with dystonia.
Case report
Two siblings (male, 14.5 years, and female, 11 years) presented for
evaluation of head tremor. Perinatal history and development had
been normal for both siblings until age 11 years, when they each
developed involuntary shaky movements of the head that worsened
during times of stress. Each had also experienced new mild school
difficulties requiring special education services at age 11 or 12 years.
The male also had symptoms of depression.
The female was examined 6 months after symptom onset (Video 1
seg.1: 00:21). She had cervical dystonia and an irregular, horizontal,
jerky head tremor of variable amplitude consistent with dystonic
tremor. She also had bilateral postural arm dystonia, most pronounced
in the left arm during writing. Her gait was narrow-based and steady.
The male was examined 2–3 years after symptom onset (Video 2,
Segment 1). He had intermittent head tremor and generalized dystonia
involving the neck, trunk, and limbs. Dystonic contractions of abdominal
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muscles were present at rest, and shoulder and limb dystonia worsened
with action, particularly walking. Dystonia did not respond to any
sensory tricks. There was mild bilateral weakness of ankle dorsiflexion.
His gait was normal-based and steady, but tandem gait was mildly
impaired, attributed at the time to his dystonia and distal weakness.
Both siblings had diminished upper extremity and patellar tendon
reflexes but normal ankle jerks and downgoing plantar responses.
Neurologic examinations and ophthalmologic examinations were
otherwise normal, specifically without evidence of limb dysmetria,
nystagmus, dysarthria, or impaired vibration or proprioception. The
Video 1. Segment 1. Sister at Presentation, Age 11. This video demonstrates cervical dystonia and dystonic tremor, no dysmetria on the finger-to-nose test,
left arm dystonia while writing, a narrow-based, steady gait, and normal tandem gait. Segment 2. Sister Post Treatment, Age 13.5. Treatment consisted of
vitamin E (inconsistently for 10 months) and trihexyphenidyl (for 2.5 years). This video demonstrates intermittent head tremor, cervical dystonia, and no dysmetria
on reaching, which was stable from the prior segment. There is subtle gait ataxia with impaired tandem gait.
Video 2. Segment 1. Brother at Presentation, Age 14.5. This video demonstrates irregular head tremor at rest and dystonia of the neck, upper limb, and
trunk that increases during reaching. There is subtle intention tremor on finger-to-nose test. Gait is normal-based and steady, with generalized dystonia, particularly
involving the right shoulder, left arm, and both lower limbs. Segment 2. Brother 18 Months after Presentation, Age 16. Eighteen months after presentation,
the patient has a broad-based, unsteady gait and dysdiadochokinesia. Generalized dystonia is unchanged. Segment 3. Brother Post Treatment, Age 17.
Treatment consisted of vitamin E (for 10 months) and trihexyphenidyl (for 2.5 years). The patient’s dysdiadochokinesia has improved significantly. He has residual
upper limb dysmetria on the finger-to-nose test. Gait ataxia and generalized dystonia were unchanged.
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initial clinical impression was of a progressive neurological disorder
characterized by dystonia, mild cognitive dysfunction, and weakness of
neuromuscular origin.
Initial investigations, including serum copper, ceruloplasmin, alpha-
fetoprotein, serum and cerebrospinal fluid lactate concentrations, and
brain magnetic resonance imaging were all normal (Figure 1). Nerve
conduction studies as well as muscle, nerve and skin biopsies were
performed in the brother. The nerve conduction study, skin biopsy,
and nerve biopsy were normal; his muscle biopsy revealed rare
myofibrillar derangement and mild, non-specific cytoarchitectural
abnormalities consistent with mild myopathic changes. Treatment
with trihexyphenidyl was initiated in both siblings. The dose in the
sister was 6 mg per day, and for the brother, 15 mg per day. The head
tremor improved in the sister; the brother reported subjective
improvement in walking, but examination findings did not clearly
improve.
One year after presentation, the brother developed dysarthria,
dysdiadochokinesia, limb dysmetria, and gait ataxia (Video 2, Segment
2). The plasma alpha-tocopherol (vitamin E) level was found to be low
in both siblings (,0.5 mg/L; reference range 5.5–18.0 mg/L).
Compound heterozygous frameshift mutations in the TTPA gene
(c.161_164del, p.R54fs and c.487delT, p.W163fs) were detected in
both siblings, confirming the diagnosis of AVED.
The siblings were started on high-dose vitamin E supplementation.
Ten months later, on 2,400 IU/day, plasma vitamin E levels were in
the normal range for both (brother, 7.4–10.4 mg/mL; sister, 7.0–7.8
mg/mL). Follow up examination demonstrated improved dysarthria
and dysdiadochokinesia in the brother (Video 2, Segment 3). His
dystonia and ataxic gait did not improve. The sister had developed
mild gait ataxia on examination (Video 1 seg 2: 00:46), although she
did not notice any impairment of balance, gait, or coordination in
daily life. Her new gait ataxia was explained, in retrospect, by a delay
in the proper initiation of her treatment because of intermittent
medication non-compliance.
Discussion
Our patients had an atypical presentation of AVED, with initial
cervical dystonia and mild cognitive dysfunction in the absence of
ataxia. Dystonia has been described in only 10 previous patients with
AVED (Table 1). In only one previous case was dystonia the
presenting symptom, in an 8-year-old patient with head jerks and
cervical dystonia that resembled myoclonus–dystonia.5 Our cases
reinforce that dystonia may precede the onset of ataxia, and highlight
cervical distribution as a characteristic feature of dystonia in AVED.
In the 12 reported cases of dystonia in patients with AVED (our two
included), the development of ataxia preceded dystonia in the majority
of patients. The average age at onset of symptoms was 9.5 years, and
the average at onset of dystonia was 15.8 years. The latency from
initial neurological symptom onset to dystonia onset was highly
variable, ranging from 0 to 26 years (nine patients included). Dystonia
occurred most frequently in the neck (75%), followed by upper limbs
(62.5%), lower limbs (50%), trunk (50%), and face (37.5%). Half of the
patients developed generalized dystonia (Table 1). Additionally,
features of dystonia may be more prevalent than previously recognized
in AVED. In one series,3 head tremor has been reported in up to 44%
of patients with AVED, and it is possible that at least some of these
patients had cervical dystonia with dystonic tremor rather than head
titubation.
The mechanism of neurologic dysfunction in AVED is unknown,
but neuronal oxidative injury has been hypothesized. Brain imaging
demonstrates cerebellar atrophy in up to 50% of cases.3,4 Other brain
regions are also affected. Animal models of AVED and post-mortem
studies of humans with secondary vitamin E deficiency have shown
evidence of degenerative changes in the substantia nigra, posterior
column, nerve roots, and peripheral nervous system.6–12 Post-mortem
studies of patients with AVED demonstrate loss of cerebellar Purkinje
cells, dying back-type posterior column degeneration with spheroids
and corpora amylacea, and lipofuscin accumulation.13,14 Ataxia in
AVED is likely caused by a combination of cerebellar and posterior
column degeneration. Whether dystonia in AVED is attributable to
injury of nigrostriatal, cerebellar, or other circuits is uncertain.
High-dose vitamin E supplementation may stop disease progression
and, in some cases, result in clinical improvement, especially in
patients with shorter disease duration.3,4 Primary prevention in
mutation-positive pre-symptomatic patients has also been reported.15
Without treatment, most patients with disease onset during childhood
(age ,18 years) become wheelchair-bound within 5–20 years of
disease onset. The brother in our report started treatment approxi-
mately 4 years after symptom onset, when he had developed significant
generalized dystonia and ataxia. After 10 months of treatment, he had
moderate improvement in hand coordination and speech, but his gait
ataxia and dystonia remained unchanged.
Figure 1. Magnetic Resonance Imaging (Brother). Coronal T2-weighted
magnetic resonance imaging showing normal cerebellum.
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The specific response of dystonia in AVED to vitamin E treatment is
variable. Dystonia has been reported to improve in two patients,3,5 and
most patients with dystonia as a feature of their disease had stabilization or
improvement of their other symptoms on high dose vitamin E (Table 1).
One patient, however, experienced progressive dystonia despite escalating
doses of vitamin E supplementation.16 There are anecdotal reports of
dystonia improvement in response to symptomatic treatment with
botulinum toxin, trihexyphenidyl,16 and clonazepam.5 The sister in our
report clearly improved with trihexyphenidyl treatment. Since AVED may
be treatable if diagnosed early, it should be considered in the differential
diagnosis of progressive dystonia, particularly when the dystonia is cervical,
or is accompanied by head tremor.




















3,600 IU; 5 mo Stable
Stumpf et al.18 4 Unsteady gait, 30 Face 800 mg; 6 mo Stable
Amiel et al.15 7 Ataxia 16 Face
UE
1,000 mg; 5 yr Improved: social
contact, speech






1,200 IU; 3 yr Stable
Yokota et al.20 30 ND ND ND ND Stable
Cavalier et al.21 3 ND ND ND ND ND








2,400 mg; 1.75 yr Improved: ataxia,
dystonia, myoclonus







2,000 mg; 5 yr Improved: ataxia
Onset: progressive
dystonia
Mariotti et al.3 8 ND ND ND 2,400 mg; 5 yr Improved: ataxia,
dystonia
Our case: female 11 Dystonic head tremor At onset Neck
UE
2,400 IU; 10 mo Onset: ataxia




2,400 IU; 10 mo Improved: dysarthria,
dysdiadochokinesia
Abbreviations: AVED, Ataxia with Vitamin E Deficiency; GD, Generalized Dystonia (defined as combination of segmental crural plus other area of body); LE, Lower
Extremity; mo, Months; ND, Not Described; UE, Upper Extremity; yr, Years.
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